rs33961459
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_000518.5(HBB):c.205C>T(p.Leu69Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L69P) has been classified as Likely benign.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.205C>T | p.Leu69Phe | missense_variant | 2/3 | ENST00000335295.4 | NP_000509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.205C>T | p.Leu69Phe | missense_variant | 2/3 | 1 | NM_000518.5 | ENSP00000333994.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
alpha Thalassemia;C0002895:Hb SS disease;C0019025:Hereditary persistence of fetal hemoglobin;C0700299:Heinz body anemia;C1840779:METHEMOGLOBINEMIA, BETA TYPE;C1858990:Dominant beta-thalassemia;C1970028:Malaria, susceptibility to;C4693822:Erythrocytosis, familial, 6;CN322236:Beta-thalassemia HBB/LCRB Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 06, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 31, 2022 | The Hb Loves Park variant (HBB: c.205C>T; p.Leu69Phe, also known as Leu68Phe when numbered from the mature protein, rs33961459, HbVar ID: 375) is reported in the literature in the heterozygous state in multiple individuals affected with microcytic anemia and in one individual with mild cyanosis (Ferreira 2006, HbVar database and references therein). In one instance, this variant was observed in an affected proband but was not found in either parent despite demonstrated parentage, indicating a de novo origin (Ferreira 2006). This variant has been reported as stable with decreased oxygen affinity. This variant is reported in ClinVar (Variation ID: 15613) and is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. The leucine at codon 69 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.742). Additionally, another amino acid substitution at this codon (p.Leu69Pro, also known as Hb Mizuho, HbVar ID: 373) has been reported de novo in multiple individuals with hemolytic anemia and is considered disease-causing (HbVar database and references therein). Based on available information, the Hb Loves Park variant is considered to be pathogenic. References: Link to HbVar: https://globin.bx.psu.edu/hbvar/hbvar.html Ferreira C et al. Hemoglobin Loves Park (beta68 (E12) Leu-->Phe): report of five cases including one originating from a de novo mutation. Am J Hematol. 2006 Apr;81(4):256-61. PMID: 16550507. - |
HEMOGLOBIN ROCKFORD Other:1
other, no assertion criteria provided | literature only | OMIM | Dec 12, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at